Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor.
D000293:Adolescent; D000906:Antibodies / Q000032:analysis*; D002543:Cerebral Hemorrhage / Q000209:etiology; D003029:Coagulants / Q000009:adverse effects* / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced*; D005164:Factor IX / Q000009:adverse effects* / Q000627:therapeutic use; D015949:Factor IXa; D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male
D000906:Antibodies; D003029:Coagulants; D005169:Factor VIII; D005164:Factor IX; D015949:Factor IXa